Literature DB >> 30720393

The Role of Glucagon-Like Peptide-1 in Energy Homeostasis.

Marzieh Salehi1,2, Jonathan Q Purnell3.   

Abstract

Energy homeostasis is coordinated by bidirectional communication pathways between the brain and peripheral organs, including adipose tissue, muscle, the pancreas, liver, and gut. Disruption of the integrated chemical, hormonal, and neuronal signals that constitute the gut-brain axis significantly contributes to disorders of metabolism and body weight. Initial studies of glucagon-like peptide-1 (GLP-1), a gut hormone released in response to the ingestion of nutrients, focused on its incretin actions to improve postprandial glucose homeostasis by enhancing meal-induced insulin secretion. However, GLP-1 is also a key player in the gut-brain regulatory axis with multiple effects on appetite and energy metabolism outside of its peripheral glucoregulatory actions. In this review, we explore the function of GLP-1 as a component of the gut-brain axis in the regulation of energy homeostasis, and consider the implications of this role for the development of therapeutic treatment options for obesity.

Entities:  

Keywords:  appetite; energy homeostasis; glucagon-like peptide-1 (GLP-1); gut–brain axis

Mesh:

Substances:

Year:  2019        PMID: 30720393      PMCID: PMC6610028          DOI: 10.1089/met.2018.0088

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  86 in total

Review 1.  Impact of Bariatric Surgery on Metabolic and Gut Microbiota Profile: a Systematic Review and Meta-analysis.

Authors:  Dimitrios E Magouliotis; Vasiliki S Tasiopoulou; Eleni Sioka; Christina Chatedaki; Dimitrios Zacharoulis
Journal:  Obes Surg       Date:  2017-05       Impact factor: 4.129

2.  Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect.

Authors:  Stephanie Sisley; Ruth Gutierrez-Aguilar; Michael Scott; David A D'Alessio; Darleen A Sandoval; Randy J Seeley
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

3.  Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency.

Authors:  Mohamad Mokadem; Juliet F Zechner; Robert F Margolskee; Daniel J Drucker; Vincent Aguirre
Journal:  Mol Metab       Date:  2013-12-11       Impact factor: 7.422

4.  A functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia.

Authors:  L Rinaman
Journal:  Am J Physiol       Date:  1999-11

5.  Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes.

Authors:  Adrian Vella; Gerlies Bock; Paula D Giesler; Duane B Burton; Denise B Serra; Monica Ligueros Saylan; Beth E Dunning; James E Foley; Robert A Rizza; Michael Camilleri
Journal:  Diabetes       Date:  2007-02-15       Impact factor: 9.461

6.  Postprandial glucagon-like peptide-1 (GLP-1) response is positively associated with changes in neuronal activity of brain areas implicated in satiety and food intake regulation in humans.

Authors:  Nicola Pannacciulli; Duc Son N T Le; Arline D Salbe; Kewei Chen; Eric M Reiman; Pietro A Tataranni; Jonathan Krakoff
Journal:  Neuroimage       Date:  2007-01-18       Impact factor: 6.556

7.  Vagally mediated effects of glucagon-like peptide 1: in vitro and in vivo gastric actions.

Authors:  Gregory M Holmes; Kirsteen N Browning; Melissa Tong; Emily Qualls-Creekmore; R Alberto Travagli
Journal:  J Physiol       Date:  2009-08-12       Impact factor: 5.182

8.  Elevated Postoperative Endogenous GLP-1 Levels Mediate Effects of Roux-en-Y Gastric Bypass on Neural Responsivity to Food Cues.

Authors:  Jennifer S Ten Kulve; Dick J Veltman; Victor E A Gerdes; Liselotte van Bloemendaal; Frederik Barkhof; Carolyn F Deacon; Jens J Holst; Madeleine L Drent; Michaela Diamant; Richard G IJzerman
Journal:  Diabetes Care       Date:  2017-11       Impact factor: 19.112

9.  Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.

Authors:  Carel W le Roux; Simon J B Aylwin; Rachel L Batterham; Cynthia M Borg; Frances Coyle; Vyas Prasad; Sandra Shurey; Mohammad A Ghatei; Ameet G Patel; Stephen R Bloom
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

Review 10.  Is GLP-1 a hormone: Whether and When?

Authors:  David D'Alessio
Journal:  J Diabetes Investig       Date:  2016-03-14       Impact factor: 4.232

View more
  6 in total

Review 1.  The Role of Nutritional Status, Gastrointestinal Peptides, and Endocannabinoids in the Prognosis and Treatment of Children with Cancer.

Authors:  Magdalena Schab; Szymon Skoczen
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

2.  Sennoside A Induces GLP-1 Secretion Through Activation of the ERK1/2 Pathway in L-Cells.

Authors:  Li Ma; Xinyu Cao; Xiaotong Ye; Jianping Ye; Yongning Sun
Journal:  Diabetes Metab Syndr Obes       Date:  2020-04-29       Impact factor: 3.168

Review 3.  An Exploration of the Role of Sugar-Sweetened Beverage in Promoting Obesity and Health Disparities.

Authors:  Desiree M Sigala; Kimber L Stanhope
Journal:  Curr Obes Rep       Date:  2021-01-07

4.  Ramulus Mori (Sangzhi) Alkaloids (SZ-A) Ameliorate Glucose Metabolism Accompanied by the Modulation of Gut Microbiota and Ileal Inflammatory Damage in Type 2 Diabetic KKAy Mice.

Authors:  Quan Liu; Shuainan Liu; Hui Cao; Wenming Ji; Caina Li; Yi Huan; Lei Lei; Yaxin Fu; Xuefeng Gao; Yuling Liu; Zhufang Shen
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

Review 5.  Resveratrol Modulates the Gut-Brain Axis: Focus on Glucagon-Like Peptide-1, 5-HT, and Gut Microbiota.

Authors:  Ji Yeon Chung; Jae-Ho Jeong; Juhyun Song
Journal:  Front Aging Neurosci       Date:  2020-11-24       Impact factor: 5.750

Review 6.  Gut microbiota in obesity.

Authors:  Bing-Nan Liu; Xiao-Tong Liu; Zi-Han Liang; Ji-Hui Wang
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.